<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7280997\results\search\drug\results.xml">
  <result pre="drugs have shown promising results. For example, the combination of" exact="chloroquine" post="and azithromycin [14]. Furthermore, the antiviral drug remdesivir and"/>
  <result pre="shown promising results. For example, the combination of chloroquine and" exact="azithromycin" post="[14]. Furthermore, the antiviral drug remdesivir and the malaria"/>
  <result pre="[14]. Furthermore, the antiviral drug remdesivir and the malaria drug" exact="chloroquine" post="have gained much attention globally as potential medications for"/>
  <result pre="antiviral drugs for the treatment of COVID-19. Oseltamivir, peramivir, and" exact="zanamivir" post="are neuraminidase inhibitors that have been used for influenza"/>
  <result pre="out of the infected cell. Another recent study suggests that" exact="ribavirin" post="if combined with interferon-Î², might be a promising drug"/>
  <result pre="no significant activity against SAS-CoV, and on the other hand," exact="ribavirin" post="is toxic with hemolysis activity [37,38]. Even though, there"/>
  <result pre="against SARS-CoV-2, or constituted a treatment option of COVID-19. 3.1." exact="Chloroquine" post="and Hydroxychloroquine Although many drugs have been reported to"/>
  <result pre="or constituted a treatment option of COVID-19. 3.1. Chloroquine and" exact="Hydroxychloroquine" post="Although many drugs have been reported to show promising"/>
  <result pre="these drugs have gained much attention like the antimalarial drugs" exact="Chloroquine" post="(CQ) and Hydroxychloroquine (HCQ) [14,49,50]. HCQ is a CQ"/>
  <result pre="gained much attention like the antimalarial drugs Chloroquine (CQ) and" exact="Hydroxychloroquine" post="(HCQ) [14,49,50]. HCQ is a CQ analog that has"/>
  <result pre="acute respiratory distress syndrome (ARDS) [52]. Currently, the use of" exact="hydroxychloroquine" post="is approved by many of COVID-19 treatment protocols, especially"/>
  <result pre="others seriously considering it [1,4,40,50]. 3.2. Remdesivir Remdesivir is an" exact="adenosine" post="nucleoside analog drug showing antiviral activity against Ebola and"/>
  <result pre="A recent report found that a combination of remdesivir and" exact="chloroquine" post="inhibited SARS-CoV-2 in vitro [56]. Very recently, the drug"/>
  <result pre="in stopping the replication mechanism of SARS-CoV-2. 3.3. Losartan and" exact="Telmisartan" post="Losartan and telmisartan are drugs that belong to the"/>
  <result pre="replication mechanism of SARS-CoV-2. 3.3. Losartan and Telmisartan Losartan and" exact="telmisartan" post="are drugs that belong to the angiotensin II receptor"/>
  <result pre="process [42]. 3.5. Lopinavir/Ritonavir It is a combination of both" exact="lopinavir" post="and ritonavir drugs that have been used for HIV"/>
  <result pre="3.5. Lopinavir/Ritonavir It is a combination of both lopinavir and" exact="ritonavir" post="drugs that have been used for HIV treatment and"/>
  <result pre="pneumonia in Saudi ArabiaNew Engl. J. Med.20123671814182010.1056/NEJMoa121172123075143 14.GautretP.LagierJ.-C.ParolaP.HoangV.T.MeddebL.MailheM.DoudierB.CourjonJ.GiordanengoV.VieiraV.E.et al.Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: Results of an open-label"/>
  <result pre="in vitro with clinically approved antiviral drugsEmerg. Infect. Dis.20041058158610.3201/eid1004.03045815200845 39.GaoJ.TianZ.YangX.Breakthrough:" exact="Chloroquine" post="phosphate has shown apparent efficacy in treatment of COVID-19"/>
  <result pre="vitro antiviral activity and projection of optimized dosing design of" exact="hydroxychloroquine" post="for the treatment of severe acute respiratory syndrome coronavirus"/>
  <result pre="effective in inhibiting SARS-CoV-2 infection in vitroCell Discov.202061410.1038/s41421-019-0132-831934347 50.ColsonP.RolainJ.-M.LagierJ.-C.BrouquiP.RaoultD.Chloroquine and" exact="hydroxychloroquine" post="as available weapons to fight COVID-19Int. J. Antimicrob. Agents20205510593210.1016/j.ijantimicag.2020.10593232145363"/>
  <result pre="J. Antimicrob. Agents20205510593210.1016/j.ijantimicag.2020.10593232145363 51.DevauxC.A.RolainJ.-M.ColsonP.RaoultD.New insights on the antiviral effects of" exact="chloroquine" post="against coronavirus: What to expect for COVID-19?Int. J. Antimicrob."/>
  <result pre="expect for COVID-19?Int. J. Antimicrob. Agents202010593810.1016/j.ijantimicag.2020.10593832171740 52.SchrezenmeierE.DornerT.Mechanisms of action of" exact="hydroxychloroquine" post="and chloroquine: Implications for rheumatologyNat. Rev. Rheumatol.20201615516610.1038/s41584-020-0372-x32034323 53.WarrenT.K.JordanR.LoM.K.RayA.S.MackmanR.L.SolovevaV.SiegelD.PerronM.BannisterR.HuiH.C.et al.Therapeutic"/>
  <result pre="of Ebola Virus RNA-Dependent RNA polymerase by remdesivirViruses20191132610.3390/v1104032630987343 56.WangM.CaoR.ZhangL.YangX.LiuJ.XuM.ShiZ.HuZ.ZhongW.XiaoG.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
  <result pre="Author Drugs Therapy Strategy Categories Mechanisms of Therapy Status [14,39,40]" exact="Chloroquine" post="phosphate/ hydroxychloroquine Anti-malariaanti-viralanti-inflammatory Increasing endosomal pH, interfering with the"/>
  <result pre="Therapy Strategy Categories Mechanisms of Therapy Status [14,39,40] Chloroquine phosphate/" exact="hydroxychloroquine" post="Anti-malariaanti-viralanti-inflammatory Increasing endosomal pH, interfering with the glycosylation of"/>
 </snippets>
</snippetsTree>
